Beck, Olof

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24‐week randomized placebo‐controlled trial

Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014) · Addiction

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 188

Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial

Jayaram-Lindström, N., Hammarberg, A., Beck, O., & Franck, J. (2008) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 185

Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics

Vorrink, S. U., Ullah, S., Schmidt, S., Nandania, J., Velagapudi, V., Beck, O., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · The FASEB Journal

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 172

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study

Konstenius, M., Jayaram-Lindström, N., Beck, O., & Franck, J. (2010) · Drug and Alcohol Dependence

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 83

Serotonin and its 5-HT1 receptor in human mastocytosis

Ritter, M., El-Nour, H., Hedblad, M.-A., Butterfield, J. H., Beck, O., Stephanson, N., Holst, M., Giscombe, R., Azmitia, E. C., & Nordlind, K. (2012) · Immunopharmacology and Immunotoxicology

Mast cells and histamineGastrointestinal motility and disorders

Cited by 17